Rainbow Robotics to Participate in Leading Prestigious Academic Conferences in Succession

Participating in Major Conferences at COEX in Seoul
Showcasing Innovative Robotics Technologies

Rainbow Robotics, a company specializing in robot platforms, announced on September 15 that it will showcase its innovative technologies at the world’s most prestigious robotics conferences, which will be held at COEX in Seoul from September 27 to October 2.

At the 56th Samsung Electronics Annual General Meeting held last March at the Suwon Convention Center in Yeongtong District, Suwon City, Gyeonggi Province, shareholders are watching a demonstration of Rainbow Robotics robots. Joint coverage by Yonhap News Agency

First, the company will participate in "CoRL 2025," the world’s leading conference in the field of robot learning, which will take place over four days starting September 27. This conference serves as a platform to share the latest research trends in robotics utilizing artificial intelligence (AI) and machine learning. Rainbow Robotics will also take part in "Humanoids 2025," a major international conference in humanoid robot technology, which will be held for three days starting September 30.

Rainbow Robotics plans to unveil new features for three products: the collaborative robot RB, the dual-arm robot RB-Y1, and the quadruped robot RBQ, highlighting the potential for technological expansion. The dual-arm robot RB-Y1, which surpassed 100 units in sales this year, will be presented alongside the RB-Y1C interface, designed for greater user convenience, as well as new option feature updates and remote control using a master arm.

The collaborative robot RB will demonstrate an automated automotive headlamp assembly solution using the dual-arm robot, in collaboration with the AI solutions company Plife. The quadruped robot RBQ-10 will roam the exhibition hall, showcasing its stable AI-powered walking technology.

Rainbow Robotics intends to leverage its participation in these exhibitions to promote academic and industrial exchange, strengthen global research collaboration, and pursue technological validation.